Home/Pipeline/SENSIMED Triggerfish® Commercialization & Data Registry

SENSIMED Triggerfish® Commercialization & Data Registry

Glaucoma Management & Monitoring

CommercialActive

Key Facts

Indication
Glaucoma Management & Monitoring
Phase
Commercial
Status
Active
Company

About Sensimed

Sensimed is a pioneer in digital ophthalmology, commercializing the first and only CE-marked and FDA-approved contact lens sensor for continuous intraocular pressure monitoring. Its core product, the SENSIMED Triggerfish®, captures 24-hour ocular dimensional change profiles, providing clinicians with unprecedented data to manage glaucoma. The company is now focused on building a global registry to analyze this data, identify pathological patterns, and drive personalized treatment approaches. Since late 2019, Sensimed has been majority-owned by Japanese contact lens giant SEED Co., Ltd., which is leveraging the partnership for expansion in Asia.

View full company profile

Therapeutic Areas